Central antiserotonin action of amitriptyline.

Pharmakopsychiatr Neuropsychopharmakol

Published: May 1979

Amitriptyline (AMI) was studied in rats snd mice in order to find out whether it had a central antiserotonin activity, previously demonstrated for doxepin - a compound chemically related to AMI. It was observed that AMI at low doses antagonized the head twitch response to L-5-hydroxytryptophan or 5-methoxytryptamine, as well as tryptamine-induced convulsions. In the hind limb flexor reflex preparation of the spinal rat AMI acted as a serotonin antagonist: when administered alone, it did not change the flexor reflex but prevented its stimulation induced by serotoninmimetics (LSD, quipazine, fenfluramine) not affecting that one evoked by noradrenalinemimetics (clinidine). At higher doses, AMI revealed a noradrenolytic activity. The results indicate that AMI, similarly as doxepin, has a central antiserotonin activity.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0028-1094622DOI Listing

Publication Analysis

Top Keywords

central antiserotonin
12
antiserotonin activity
8
flexor reflex
8
ami
6
antiserotonin action
4
action amitriptyline
4
amitriptyline amitriptyline
4
amitriptyline ami
4
ami studied
4
studied rats
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!